L. G. Vologzhanina

L. G. Vologzhanina

Auto-generated profile, based on publicly available information

L. G. Vologzhanina

Perm State Medical University named after Academician E.A. Wagner of the Ministry of Health of the Russian Federation

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2021 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
LLL. B. Lazebnik
L. B. Lazebnik
EGE. V. Golovanova
E. V. Golovanova
SAS. A. Alekseenko
S. A. Alekseenko
ABA. O. Bueverov
A. O. Bueverov
EPE. Yu. Plotnikova
E. Yu. Plotnikova
ЮЦЮ. В. Цыганова
Ю. В. Цыганова
Justification Given the large number of reports on the peculiarities of liver lesions during the Sars-Cov-2 infection [1], a team of experts who participated in the 23rd Congress of the Scientific Society of Gastroenterologists of Russia and 15 National Congress of Therapists of November 19, 2020 decided to make additions to the Russian Consensus of “Hyperammonemia in Adults” published early 2020 [2, 3].

30 December 2024 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
IMIgor V. Maev
Igor V. Maev
VAV. A. Akhmedov
V. A. Akhmedov
LVL. G. Vologzhanina
L. G. Vologzhanina
ADA. I. Dolgushina
A. I. Dolgushina
ЮЦЮ. В. Цыганова
Ю. В. Цыганова
Лекарственные поражения печени (ЛПП) у взрослых

7 April 2021 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
LVL. G. Vologzhanina
L. G. Vologzhanina
EBE. N. Borodina
E. N. Borodina
OIO. A. Igumnova
O. A. Igumnova
ATA. A. Trapeznikova
A. A. Trapeznikova
The growth of cognitive impairment (CI) in clinical practice makes us search for their new pathogenetic mechanisms, among which the effect of intestinal microbiota on the brain is currently being actively studied. The mechanisms of interaction of the axis “brain - microbiota” have not been completely studied. The aim of this study was to confirm the possible effect on the brain of the neurotoxin ammonia, which rises in the blood due to the syndrome of excessive bacterial growth (SIBO). Materials and methods: The article presents data from a clinical observation, which included an examination of 70 patients of the gastrocenter in Perm with dyspepsia syndrome, who studied changes in the intestinal microbiota, the level of ammonia of capillary blood, and cognitive impairment, and conducted a correlation analysis. Results: According to the results of a statistical analysis of the obtained data, we did not find any significant changes or significant correlations between the studied parameters. However, the identified tendency in the connection “SIBO - hyperammonemia - cognitive impairment” suggests that the presence of SIBO can aggravate the severity of not only existing gastroenterological manifestations, but also be a risk factor for hyperammonemia, as well as contribute to the formation of impaired human cognitive functions.

30 December 2024 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
LLL. B. Lazebnik
L. B. Lazebnik
STS. V. Turkina
S. V. Turkina
TET. V. Ermolova
T. V. Ermolova
Larisa V. TarasovaLarisa V. Tarasova
Larisa V. Tarasova
EPE. Yu. Plotnikova
E. Yu. Plotnikova
IKI. N. Kupriyanova
I. N. Kupriyanova
An increase in the amount of ammonia-ammonium in tissues plays a significant role in the development of human pathology. The appearance of an increasing number of publications emphasizes the urgency of the problem. A team of experts who took part in the XXVII Congress of the Scientific Society of Gastroenterologists of Russia (NOGR) on November 14, 2024 decided to make adjustments to the text of the Russian Consensus “Hyperammonemia in Adults” published in 2021 (Version 2021).

23 July 2025 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
SOSergey Okovityi
Sergey Okovityi
KRK. L. Raikhelson
K. L. Raikhelson
VAV. А. Akhmedov
V. А. Akhmedov
LVL. G. Vologzanina
L. G. Vologzanina
OGO. A. Gladkov
O. A. Gladkov
OKO. V. Khlynova
O. V. Khlynova
A joint council of experts in the field of hepatology reviewed the results of experimental and clinical studies evaluating the efficacy of hepatotropic drugs (ademetionine, ursodeoxycholic acid, ornithine, bicyclol, morpholinium tiazotate, phospholipids, a fixed combination of inosine + meglumine + methionine + nicotinamide + succinic acid), glucocorticoids, extracorporeal detoxification methods in drug-induced liver injury (DILI); inclusion of these medications and treatment methods in clinical guidelines in various countries was analyzed. Indications for the use of hepatotropic drugs were formulated depending on the pattern of DILI (hepatocellular, cholestatic, mixed), as well as in some DILI phenotypes.

1 April 2026 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Closed access
VIVladimir Ivashkin
Vladimir Ivashkin
ODOxana M. Drapkina
Oxana M. Drapkina
KRK. L. Raikhelson
K. L. Raikhelson
SOSergey Okovityi
Sergey Okovityi
MMM. V. Maevskaya
M. V. Maevskaya
YTYu. V. Tsyganova
Yu. V. Tsyganova
Aim. The clinical guidelines are intended to provide information support for making decisions by gastroenterologists, general practitioners and internists that will improve the quality of medical care for patients with drug-induced liver injury, taking into account the latest clinical data and principles of evidence-based medicine. Key points. Clinical guidelines contain information about current views on etiology, risk factors and pathogenesis of drug-induced liver injury, peculiarities of its clinical course. Also, the recommendations provide information on current methods of laboratory and instrumental diagnostics, invasive and non-invasive tools for drug-induced liver injury disease and its clinical phenotypes assessment; approaches to its treatment, considering the presence of comorbidities, features of dispensary monitoring and prophylaxis. The information is illustrated with algorithms of differential diagnosis and physician’s actions. In addition, there is information for the patient and criteria for assessing the quality of medical care. Conclusion. Awareness of specialists in the issues of diagnosis, treatment and follow-up of patients with drug- induced liver injury contributes to the timely diagnosis and initiation of treatment, which in the long term will significantly affect their prognosis and quality of life.